Trust Company of Vermont’s Anterix ATEX Stock Holding History

Trust Company of Vermont’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$188	–	1054
2024 Q3	$188	Buy	+5	New	+$193	﹤0.01%	1021

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GECH

Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trust Company of Vermont's ATEX Position: Q4 2024 in Review

Trust Company of Vermont sold out of Anterix (ATEX) in Q4 2024, closing a stake of 5 shares — an estimated $188 sold.

Trust Company of Vermont first reported a position in ATEX in Q3 2024 and held it in 1 quarter. The position peaked at $188 in Q3 2024. 115 funds tracked by Wall St. Rank hold ATEX as of Q4 2024.

Trust Company of Vermont reported no remaining Anterix position as of Q4 2024 after selling out during the quarter.
Trust Company of Vermont sold 5 Anterix shares in Q4 2024, an estimated $188.
Trust Company of Vermont first reported a position in Anterix in Q3 2024 and held it in 1 quarter.
Trust Company of Vermont's Anterix position peaked at $188 in Q3 2024.
115 funds tracked by Wall St. Rank held Anterix as of Q4 2024.

Based on Trust Company of Vermont's 13F filing for Q4 2024, filed 15 Jan 2025.